{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T18:48:42Z","timestamp":1792867722068,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["No.20230797, No. 20241558"],"award-info":[{"award-number":["No.20230797, No. 20241558"]}]},{"name":"Innovative Research Team Support Program of the Fourth Hospital of Hebei Medical University","award":["2023C15"],"award-info":[{"award-number":["2023C15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04113-5","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T09:36:48Z","timestamp":1764581808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["E2F7 promotes ESCC progression and cisplatin resistance through transcriptional activation of DVL3 and the Wnt signaling pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaoxu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"4113_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4113_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353.","journal-title":"J Natl Cancer Cent"},{"key":"4113_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-020-00323-3","volume":"5","author":"YM Yang","year":"2020","unstructured":"Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther. 2020;5:229.","journal-title":"Signal Transduct Target Ther"},{"key":"4113_CR4","first-page":"739","volume":"6","author":"J DeGregori","year":"2006","unstructured":"DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in Transcription, proliferation and apoptosis. Curr Mol Med. 2006;6:739\u201348.","journal-title":"Curr Mol Med"},{"key":"4113_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrc2696","volume":"9","author":"HZ Chen","year":"2009","unstructured":"Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer. 2009;9:785\u201397.","journal-title":"Nat Rev Cancer"},{"key":"4113_CR6","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1038\/sj.emboj.7600481","volume":"23","author":"C Attwooll","year":"2004","unstructured":"Attwooll C, Lazzerini Denchi E, Helin K. The E2F family: specific functions and overlapping interests. EMBO J. 2004;23:4709\u201316.","journal-title":"EMBO J"},{"key":"4113_CR7","doi-asserted-by":"publisher","first-page":"e34362","DOI":"10.1016\/j.heliyon.2024.e34362","volume":"10","author":"KQ Chen","year":"2024","unstructured":"Chen KQ, Lei HB, Liu X, Wang SZ. The roles of E2F7 in cancer: current knowledge and future prospects. Heliyon. 2024;10:e34362.","journal-title":"Heliyon"},{"key":"4113_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/09674845.2018.1520066","volume":"76","author":"C Wang","year":"2019","unstructured":"Wang C, Li S, Xu J, Niu W, Li S. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway. Br J Biomed Sci. 2019;76:17\u201323.","journal-title":"Br J Biomed Sci"},{"key":"4113_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/mc.23454","volume":"61","author":"F Hao","year":"2022","unstructured":"Hao F, Wang N, Zhang Y, Xu W, Chen Y, Fei X, et al. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1\/SOX4\/Anillin axis via repressing miRNA-383-5p transcription. Mol Carcinog. 2022;61:975\u201388.","journal-title":"Mol Carcinog"},{"key":"4113_CR10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41416-020-01032-y","volume":"123","author":"R Yang","year":"2020","unstructured":"Yang R, Wang M, Zhang G, Bao Y, Wu Y, Li X, et al. E2F7-EZH2 axis regulates PTEN\/AKT\/mTOR signalling and glioblastoma progression. Br J Cancer. 2020;123:1445\u201355.","journal-title":"Br J Cancer"},{"key":"4113_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13046-020-01739-z","volume":"39","author":"F Teng","year":"2020","unstructured":"Teng F, Zhang JX, Chang QM, Wu XB, Tang WG, Wang JF, et al. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p\/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:235.","journal-title":"J Exp Clin Cancer Res"},{"key":"4113_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13:165.","journal-title":"J Hematol Oncol"},{"key":"4113_CR13","doi-asserted-by":"publisher","first-page":"153873","DOI":"10.1016\/j.prp.2022.153873","volume":"235","author":"G Qiang","year":"2022","unstructured":"Qiang G, Yu Q, Su K, Guo Y, Liu D, Liang C. E2F1-activated LINC01224 drives esophageal squamous cell carcinoma cell malignant behaviors via targeting miR-6884-5p\/DVL3 axis and activating Wnt\/beta-catenin signaling pathway. Pathol Res Pract. 2022;235:153873.","journal-title":"Pathol Res Pract"},{"key":"4113_CR14","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"4113_CR15","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022;50:D165\u201373.","journal-title":"Nucleic Acids Res"},{"key":"4113_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12:996\u20131006.","journal-title":"Genome Res"},{"key":"4113_CR17","first-page":"580","volume":"45","author":"FF Li","year":"2023","unstructured":"Li FF, Wang Y, Gu JH, Zhang YM, Liu FS, Ni ZH. E2F family play important roles in tumorigenesis. Yi Chuan. 2023;45:580\u201392.","journal-title":"Yi Chuan"},{"key":"4113_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10863-025-10066-x","volume":"57","author":"W Yun","year":"2025","unstructured":"Yun W, Mao C, Yuan Y. E2F7 transcriptionally upregulates SPC24 to mediate aerobic Glycolysis and facilitate stemness of breast cancer. J Bioenerg Biomembr. 2025;57:303\u201313.","journal-title":"J Bioenerg Biomembr"},{"key":"4113_CR19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.4014\/jmb.2308.08026","volume":"34","author":"B Jiang","year":"2024","unstructured":"Jiang B, Yan B, Yang H, Geng H, Li P, Transcription Factor. E2F7 hampers the killing effect of NK cells against colorectal cancer cells via activating RAD18 transcription. J Microbiol Biotechnol. 2024;34:920\u20139.","journal-title":"J Microbiol Biotechnol"},{"key":"4113_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13046-018-0927-8","volume":"37","author":"YS Ma","year":"2018","unstructured":"Ma YS, Lv ZW, Yu F, Chang ZY, Cong XL, Zhong XM, et al. MicroRNA-302a\/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7\/AKT axis. J Exp Clin Cancer Res. 2018;37:252.","journal-title":"J Exp Clin Cancer Res"},{"key":"4113_CR21","first-page":"3045","volume":"8","author":"F Deng","year":"2015","unstructured":"Deng F, Zhou K, Cui W, Liu D, Ma Y. Clinicopathological significance of wnt\/beta-catenin signaling pathway in esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8:3045\u201353.","journal-title":"Int J Clin Exp Pathol"},{"key":"4113_CR22","first-page":"7716","volume":"22","author":"XQ Chen","year":"2018","unstructured":"Chen XQ, Jiang J, Wang XT, Zhang CL, Ji AY, Chen XJ. Role and mechanism of Dvl3 in the esophageal squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2018;22:7716\u201325.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4113_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40364-021-00323-7","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhao T, Zhang S, Wang J, Chen Y, Zhao H, et al. The Wnt signaling pathway in tumorigenesis, Pharmacological targets, and drug development for cancer therapy. Biomark Res. 2021;9:68.","journal-title":"Biomark Res"},{"key":"4113_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10735-023-10145-6","volume":"54","author":"L Wang","year":"2023","unstructured":"Wang L, Wang Y, Wang C, Yang K, Ye G. CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer. J Mol Histol. 2023;54:489\u201398.","journal-title":"J Mol Histol"},{"key":"4113_CR25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mc.20675","volume":"49","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Yang ZQ, Wang Y, Miao Y, Liu Y, Dai SD, et al. Dishevelled-1 and dishevelled-3 affect cell invasion mainly through canonical and noncanonical Wnt pathway, respectively, and associate with poor prognosis in nonsmall cell lung cancer. Mol Carcinog. 2010;49:760\u201370.","journal-title":"Mol Carcinog"},{"key":"4113_CR26","doi-asserted-by":"publisher","first-page":"e2407681","DOI":"10.1002\/advs.202407681","volume":"12","author":"Z Deng","year":"2025","unstructured":"Deng Z, Sun S, Zhou N, Peng Y, Cheng L, Yu X, et al. PNPO-Mediated oxidation of DVL3 promotes multiple myeloma malignancy and osteoclastogenesis by activating the Wnt\/beta-Catenin pathway. Adv Sci (Weinh). 2025;12:e2407681.","journal-title":"Adv Sci (Weinh)"},{"key":"4113_CR27","doi-asserted-by":"publisher","first-page":"e53597","DOI":"10.1371\/journal.pone.0053597","volume":"8","author":"HT Kwan","year":"2013","unstructured":"Kwan HT, Chan DW, Cai PC, Mak CS, Yung MM, Leung TH, et al. AMPK activators suppress cervical cancer cell growth through Inhibition of DVL3 mediated Wnt\/beta-catenin signaling activity. PLoS ONE. 2013;8:e53597.","journal-title":"PLoS ONE"},{"key":"4113_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-023-04120-8","volume":"21","author":"Z Li","year":"2023","unstructured":"Li Z, Yang Z, Liu W, Zhu W, Yin L, Han Z, et al. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt\/beta-catenin\/c-Myc\/SOX2 pathway in colorectal cancer. J Transl Med. 2023;21:302.","journal-title":"J Transl Med"},{"key":"4113_CR29","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.7150\/jca.45493","volume":"12","author":"J Yu","year":"2021","unstructured":"Yu J, Wang W, Liu B, Gu J, Chen S, Cui Y, et al. Demethylzelasteral inhibits proliferation and EMT via repressing Wnt\/beta-catenin signaling in esophageal squamous cell carcinoma. J Cancer. 2021;12:3967\u201375.","journal-title":"J Cancer"},{"key":"4113_CR30","doi-asserted-by":"publisher","first-page":"e385223","DOI":"10.1590\/acb385223","volume":"38","author":"D Wei","year":"2023","unstructured":"Wei D, Ma Z, Zhu T, Wang H, Wang B, Fu L, et al. miR-29c-3p represses the angiogenesis of esophageal squamous cell carcinoma by targeting SERPINH1 to regulate the Wnt signaling pathway. Acta Cir Bras. 2023;38:e385223.","journal-title":"Acta Cir Bras"},{"key":"4113_CR31","doi-asserted-by":"publisher","first-page":"27037","DOI":"10.1038\/s41598-024-77811-x","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhu Z, Ren N, Wang D, Zeng X, Zhang N. Implication of CCNG1 in radiosensitivity via the Wnt\/beta-catenin pathway in esophageal squamous cells. Sci Rep. 2024;14:27037.","journal-title":"Sci Rep"},{"key":"4113_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1566524019666190405121139","volume":"19","author":"M Zhang","year":"2019","unstructured":"Zhang M, Wang J, Gao T, Chen X, Xu Y, Yu X, et al. Inhibition of SOX15 sensitizes esophageal squamous carcinoma cells to Paclitaxel. Curr Mol Med. 2019;19:349\u201356.","journal-title":"Curr Mol Med"},{"key":"4113_CR33","doi-asserted-by":"publisher","first-page":"12412","DOI":"10.18632\/aging.102580","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu J, Xue N, Guo Y, Niu K, Gao L, Zhang S, et al. CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217\/Wnt3 pathway. Aging. 2019;11:12412\u201327.","journal-title":"Aging"},{"key":"4113_CR34","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-019-12203-8","volume":"10","author":"DB Bernkopf","year":"2019","unstructured":"Bernkopf DB, Bruckner M, Hadjihannas MV, Behrens J. An Aggregon in conductin\/axin2 regulates Wnt\/beta-catenin signaling and holds potential for cancer therapy. Nat Commun. 2019;10:4251.","journal-title":"Nat Commun"},{"key":"4113_CR35","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"EH Jho","year":"2002","unstructured":"Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172\u201383.","journal-title":"Mol Cell Biol"},{"key":"4113_CR36","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1126\/science.285.5435.1923","volume":"285","author":"J Roose","year":"1999","unstructured":"Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, et al. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999;285:1923\u20136.","journal-title":"Science"},{"key":"4113_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12079-016-0320-3","volume":"10","author":"M Moghbeli","year":"2016","unstructured":"Moghbeli M, Abbaszadegan MR, Golmakani E, Forghanifard MM. Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma. J Cell Commun Signal. 2016;10:129\u201335.","journal-title":"J Cell Commun Signal"},{"key":"4113_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12885-024-12017-y","volume":"24","author":"J Meng","year":"2024","unstructured":"Meng J, Qian W, Yang Z, Gong L, Xu D, Huang H, et al. p53\/E2F7 axis promotes Temozolomide chemoresistance in glioblastoma multiforme. BMC Cancer. 2024;24:317.","journal-title":"BMC Cancer"},{"key":"4113_CR39","doi-asserted-by":"publisher","first-page":"152964","DOI":"10.1016\/j.prp.2020.152964","volume":"216","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Zhuang K, Han K, Tang H, Wang Y, Si W, et al. Silencing DVL3 defeats MTX resistance and attenuates stemness via Notch signaling pathway in colorectal cancer. Pathol Res Pract. 2020;216:152964.","journal-title":"Pathol Res Pract"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04113-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04113-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04113-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:06:16Z","timestamp":1767679576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04113-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4113"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04113-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University (No. 2022KY105). Written informed consent was obtained from all participants prior to their inclusion in the study, in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}